Etofibrate

This classification denotes an anti-lipidemic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 23TF67G79M. European Medicines Agency schedules Etofibrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07321MIG. Etofibrate generally arises in the molecular formula C18H18CLNO5. The term ETOFIBRATE is an International Non-Proprietary Name or INN. ETOFIBRATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etofibrate under HS 29333999 and SITC 51574. As of Q4 2014, ETOFIBRATE remains the US FDA Preferred Term for this commodity. Etofibrate bears US NLM identifiers UMLS ID C0059869 and NCI Concept Code C65588. SMILES: Clc1ccc(OC(C)(C)C(=O)OCCOC(=O)c2cccnc2)cc1.